Quest Diagnostics
DGX
#1047
Rank
โ‚น2.242 T
Marketcap
โ‚น20,260
Share price
1.45%
Change (1 day)
31.56%
Change (1 year)
Quest Diagnostics is an American clinical laboratory company offering access to diagnostic testing services for cancer, cardiovascular disease, infectious disease, neurological disorders and employment and court ordered drug testing.

EPS for Quest Diagnostics (DGX)

EPS in 2026 (TTM): โ‚น819.41

According to Quest Diagnostics 's latest financial reports the company's current EPS (TTM) is โ‚น885.41. In 2025 the company made an earnings per share (EPS) of โ‚น856.44 an increase over its 2024 EPS that were of โ‚น751.20.

EPS history for Quest Diagnostics from 2012 to 2026

Annual EPS

Year EPS Change
2026 (TTM)โ‚น819.41-4.32%
2025โ‚น856.4414.01%
2024โ‚น751.202.5%
2023โ‚น732.85-5.83%
2022โ‚น778.23-49.21%
2021โ‚น1,53249.72%
2020โ‚น1,02366.67%
2019โ‚น614.0918%
2018โ‚น520.43-4.26%
2017โ‚น543.6023.19%
2016โ‚น441.26-7.11%
2015โ‚น475.0528.46%
2014โ‚น369.81-31.61%
2013โ‚น540.7160.46%
2012โ‚น336.98

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
LabCorp
LH
โ‚น1,097 23.88%๐Ÿ‡บ๐Ÿ‡ธ USA
Psychemedics
PMD
-โ‚น68.73-107.76%๐Ÿ‡บ๐Ÿ‡ธ USA
NeoGenomics
NEO
-โ‚น74.35-108.40%๐Ÿ‡บ๐Ÿ‡ธ USA
Qiagen
QGEN
โ‚น188.09-78.76%๐Ÿ‡ณ๐Ÿ‡ฑ Netherlands
Enzo Biochem
ENZB
-โ‚น20.28-102.29%๐Ÿ‡บ๐Ÿ‡ธ USA